Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CD2475/101 (sarecycline) in acne vulgaris
NCT01320033Phase 2Completed
- Sponsor
- Galderma
- Start
- Mar 2011
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sarecycline in acne vulgaris, sponsored by Galderma. Started Mar 2011; status: completed.
02
Drugs
sarecycline
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT01320033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01320033.